[1] Cohen JC,Horton JD,Hobbs HH. Human fatty liver disease,old questions and new insights. Science,2011,332 (6037):1519-1523. [2] 中华医学会. 非酒精性脂肪性肝病诊疗指南. 中华肝脏病杂志,2010,18(3):163-170. [3] 谭彦芳,赵彩彦. 非酒精性脂肪性肝病药物治疗进展. 实用肝脏病杂志,2013,16(4):378-381. [4] 马振增,陆伦根. 非酒精性脂肪性肝病与肝硬化. 实用肝脏病杂志,2016,19(2):135-138. [5] Bellizzi D,Dato S,Cavalcante P,et al. Characterization of a bidirectional promoter shared between two human genes related to aging: SIRT3 and PSMD13. Genomics,2007,89(1):143-150. [6] Hirschey MD,Shimazu T,Goetzman E,et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation.Nature,2010,464 (7285):121-125. [7] Bause AS,Haigis MC. SIRT3 regulation of mitochondrial oxidative stress. Exp Gerontol,2013,48 (7):634-639. [8] 尹力,叶雪瑞,刘新新,等. Sirt3对过氧化氢诱导的骨髓间充质干细胞凋亡的保护作用.现代生物医学进展,2015,15(31):6039-6042. [9] 殷玥,李晨,余露,等. 有氧间歇训练抑制高脂喂养小鼠海马神经元损伤. 中华神经外科疾病研究杂志,2016,15(3):213-216. [10] Cho EH. SIRT3 as a regulator of non-alcoholic fatty liver disease.J Lifestyle Med,2014,4 (2):80-85. [11] 李燕强,华伟娜,杨俊霞,等. 白藜芦醇对肝脂肪积累的抑制作用及其分子机制.中国医药导报,2012,9(33):9-11. [12] Kleiner DE,Brunt EM,Van Natta M,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology,2005,41(6):1313-1321. [13] FlamengW,Andres J,Ferdinande P,et a1. Mitochondrial function in myocardial stunning. J Mol Cell Cardiol,1991,23:1-11. [14] Michan S,Sinclair D. Sirtuins in mammals:insights into their biological function.Biochem J,2007,404 (1):1-13. [15] Park J,Chen Y,Tishkoff DX,et al. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell,2013,50(6):919-930. [16] Zhang D,Liu ZX,Choi CS,et al. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci U S A,2007,104(43):17075-17080. [17] Hirschey MD,Shimazu T,Jing E,et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell,2011,44(2):177-190. [18] Shi T,Fan GQ,Xiao SD. SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells.J Dig Dis,2010,11(1):55-62. [19] Onyango P,Celic I,McCaffery JM,et al. SIRT3,a human SIR2 homologue,is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci U S A,2002,99(21):13653-13658. [20] Cooper HM,Spelbrink JN. The human SIRT3 protein deacetylase is exclusively mitochondrial. Biochem J,2008,411(2):279-285. [21] Sundaresan NR,Samant SA,Pillai VB,et al. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70.Mol Cell Biol,2008,28(20):6384-6401. |